Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline.
• Current treatments for AD offer limited efficacy, highlighting the need for novel therapeutic strategies.
• Phenolic acids and their derivatives have emerged as potential agents due to their antioxidant and anti-inflammatory properties.

Purpose of the Study:

• To review the role of phenolic acids as inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).
• To examine the inhibitory effects of phenolic acids on amyloid-beta peptide (Aβ) fibril formation.
• To summarize evidence from in vitro, ex vivo, and in vivo studies on cognitive enhancement and AD prevention/treatment.

Main Methods:

• Literature review of studies investigating phenolic acids and Alzheimer's disease.
• Analysis of structure-activity relationships for phenolic acid derivatives as enzyme inhibitors.
• Compilation of data from experimental studies (in vitro, ex vivo, in vivo) on cognitive effects.

Main Results:

• Phenolic acids effectively inhibit both AChE and BChE, enzymes implicated in AD pathogenesis.
• These compounds demonstrate significant potential in preventing the aggregation of amyloid-beta peptides into toxic fibrils.
• Studies indicate that phenolic acids can improve cognitive function and offer protective effects against AD progression.

Conclusions:

• Phenolic acids represent a promising class of compounds for the development of novel Alzheimer's disease therapeutics.
• Their dual mechanism of action, targeting both cholinergic deficits and amyloid pathology, makes them attractive candidates.
• Further research into specific phenolic acid derivatives could lead to effective strategies for AD prevention and treatment.